Drug-resistant pandemic (H1N1) 2009, South Korea

Emerging Infectious Diseases

Volumn 17, Issue 4, 2011, Pages 702-704

  Shin, Soo Youn ^a   Kang, Chun ^a   Gwack, Jin ^a   Kim, Joon Hyung ^a   Kim, Hyun Su ^a   Kang, Young A ^a   Lee, Ha Gyung ^a   Kim, Jin Seok ^a   Lee, Jong Koo ^a   Kim, Sung Han ^b  

^a Korea Centers for Disease Control and Prevention   (South Korea)

^b University of Ulsan College of Medicine   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

AMANTADINE; OSELTAMIVIR; PERAMIVIR; RIBAVIRIN; VIRUS SIALIDASE; ZANAMIVIR;

2009 H1N1 INFLUENZA; ADULT RESPIRATORY DISTRESS SYNDROME; ANTIVIRAL RESISTANCE; ANTIVIRAL THERAPY; ARTICLE; BACTERIAL PNEUMONIA; CHEMOPROPHYLAXIS; CHILD; CLINICAL ARTICLE; CLINICAL FEATURE; COMBINATION CHEMOTHERAPY; DISEASE COURSE; DISEASE TRANSMISSION; DRUG MEGADOSE; DRUG TREATMENT FAILURE; ENZYME ASSAY; FLU LIKE SYNDROME; GENE SEQUENCE; GENOTYPE; HUMAN; IMMUNE DEFICIENCY; MONOTHERAPY; MORTALITY; PRESCHOOL CHILD; SCHOOL CHILD; SOUTH KOREA; TREATMENT OUTCOME; VIRUS MUTATION;

ADOLESCENT; ADULT; ANTIVIRAL AGENTS; CHILD; CHILD, PRESCHOOL; DRUG RESISTANCE, VIRAL; FEMALE; HUMANS; INFANT; INFLUENZA A VIRUS, H1N1 SUBTYPE; INFLUENZA, HUMAN; MALE; MIDDLE AGED; MUTATION; OSELTAMIVIR; REPUBLIC OF KOREA; TREATMENT OUTCOME; VIRAL PROTEINS; YOUNG ADULT;

EID: 79953673856     PISSN: 10806040     EISSN: 10806059     Source Type: Journal    
DOI: 10.3201/eid1704.101467     Document Type: Article

References (12)

1. Cao B, Li XW, Mao Y, Wang J, Lu HZ, Chen YS, et al. Clinical features of the initial cases of 2009 pandemic influenza A (H1N1) virus infection in China. N Engl J Med. 2009;361:2507-2517. DOI: 10.1056/NEJMoa0906612
2. Yi H, Lee JY, Hong EH, Kim MS, Kwon D, Choi JH, et al. Oseltamivir-resistant infection of pandemic (H1N1) 2009 infl uenza virus in South Korea. Emerg Infect Dis. 2010;16:1938-1942.
3. Memoli MJ, Hrabal RJ, Hassantoufighi A, Eichelberger MC, Taubenberger JK. Rapid selection of oseltamivir- and peramivir-resistant pandemic H1N1 virus during therapy in 2 immunocompromised hosts. Clin Infect Dis. 2010;50:1252-1253. DOI: 10.1086/651605
4. Chan PA, Connell NT, Gabonay AM, Westley B, Larkin JM, Larosa SP, et al. Oseltamivir-resistant 2009-2010 pandemic infl uenza A (H1N1) in an immunocompromised patient. Clin Microbiol Infect. 2010;16:1576-1578. DOI: 10.1111/j.1469-0691.2010.03212.x
5. Tramontana AR, George B, Hurt AC, Doyle JS, Langan K, Reid AB, et al. Oseltamivir resistance in adult oncology and hematology patients infected with pandemic (H1N1) 2009 virus, Australia. Emerg Infect Dis. 2010;16:1068-1075. DOI: 10.3201/eid1607.091691
6. Whitley RJ, Hayden FG, Reisinger KS, Young N, Dutkowski R, Ipe D, et al. Oral oseltamivir treatment of infl uenza in children. Pediatr Infect Dis J. 2001;20:127-133. DOI: 10.1097/00006454-200102000-00002
7. Aoki FY, Boivin G, Roberts N. Influenza virus susceptibility and resistance to oseltamivir. Antivir Ther. 2007;12:603-616.
8. World Health Organization. Updated interim recommendations for the use of antiviral medications in the treatment and prevention of influenza for the 2009-2010 seasons [cited 2010 Dec 23]. http://www.cdc.gov/h1n1flu/recommendations.htm
9. Mandelboim M, Hindiyeh M, Meningher T, Mendelson E. Possible transmission of pandemic (HIN1) 2009 virus with oseltamivir resistance. Emerg Infect Dis. 2010;16:873-874.
10. Le QM, Wertheim HF, Tran ND, van Doorn HR, Nguyen TH, Horby P. A community cluster of oseltamivir-resistant cases of 2009 H1N1 infl uenza. N Engl J Med. 2010;362:86-87. DOI: 10.1056/NEJMc0910448
11. Moore C, Galiano M, Lackenby A, Abdelrahman T, Barnes R, Evans MR, et al. Evidence of person-to-person transmission of oseltamivirresistant pandemic infl uenza A(H1N1) 2009 virus in a hematologic unit. J Infect Dis. 2011;203:18-24. DOI: 10.1093/infdis/jiq007
12. Ilyushina NA, Seiler JP, Rehg JE, Webster RG, Govorkova EA. Effect of neuraminidase inhibitor-resistant mutations on pathogenicity of clade 2.2 A/Turkey/15/06 (H5N1) influenza virus in ferrets. PLoS Pathog. 2010;6:e1000933. DOI: 10.1371/journal.ppat.1000933